HY-139330-5mg
|
MedChemexpress LLC
|
MGH-CP1 [CAS 896657-58-2]
|
|
Cancer-programmed cell death
|
|
HY-139330-50mg
|
MedChemexpress LLC
|
MGH-CP1 [CAS 896657-58-2]
|
|
Cancer-programmed cell death
|
|
HY-10230-1mg
|
MedChemexpress LLC
|
Midostaurin [CAS 120685-11-2]
|
|
Cancer-Kinase/protease
|
|
HY-10230-10mg
|
MedChemexpress LLC
|
Midostaurin [CAS 120685-11-2]
|
|
Cancer-Kinase/protease
|
|
HY-10230-100mg
|
MedChemexpress LLC
|
Midostaurin [CAS 120685-11-2]
|
|
Cancer-Kinase/protease
|
|
HY-10230-5mg
|
MedChemexpress LLC
|
Midostaurin [CAS 120685-11-2]
|
|
Cancer-Kinase/protease
|
|
HY-10230-50mg
|
MedChemexpress LLC
|
Midostaurin [CAS 120685-11-2]
|
|
Cancer-Kinase/protease
|
|
HY-10230-1mL
|
MedChemexpress LLC
|
Midostaurin [CAS 120685-11-2] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-10254-10mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-100mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-25mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-5mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-50mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-1mL
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|